NC-AESARA
Expansion of AESARA Europe with the Appointment of Italian pharmaceutical industry veteran, Patrizia Berto
AESARA (www.aesara.com) is delighted to announce the appointment of industry veteran value & access strategist Patrizia Berto PharmD, MBA, to the European Strategic Partnerships team.
Based in Italy, within the AESARA Europe team, Patrizia will bring: depth of insight into the Italian market; a broader European perspective on health technology assessment (HTA), pricing & reimbursement; and globally-applicable technical expertise in health economics and outcomes research (HEOR). Her exceptional career includes 10 years at pharmaceutical industry giant Glaxo, 12 years as professor of pharmacoeconomics at the University of Padova and a wealth of experience as a senior value & access strategy consultant, advising innovative biotechnology, pharmaceutical and med tech clients.
Gavin Outteridge, Managing Director of AESARA Europe said, “I am thrilled to be able to connect Patrizia to AESARA’s clients. Adding her depth of expertise strengthens our differentiated, pan-European value & access strategy offer. Her direct experience of price, access and reimbursement in the Italian health system is a particular value-add.”
Ruslan Horblyuk, Global Head of AESARA Strategic Partnerships added: “Patrizia’s arrival further strengthens AESARA’s ability to be thought partners for our customers, across all aspects of value, access and HEOR, combining strong global and local perspectives. She brings deep expertise, breadth of experience and a charming bedside manner to her client work, and we’re very pleased to welcome her to the Strategic Partnerships team.”
“I am truly enthusiastic about joining the AESARA team at this time in my career, when I can really deploy all my competence and experience in favour of such a talented and skilled group of professionals. I hope to teach some, to learn a lot and to put all my experience at the service of AESARA’s clients,” said Patrizia Berto on her appointment as Principal, AESARA Europe.
About AESARA
AESARA is a market access agency with a focused purpose to impact healthcare decision-making to improve people’s lives. Established in 2016, we are a woman and minority-owned company with biopharma seasoned industry professionals in the U.S., Canada, and Europe. Our diverse team is passionate about delivering to our client’s transformative market access strategies and innovative digital communication solutions. For more information, please visit www.aesara.com and connect with AESARA on Twitter and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005716/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT-SOFTWARE1.2.2023 09:01:43 CET | Press release
FPT Software Europe Supports DAX Company Covestro With Cloud Migration
KIOXIA1.2.2023 07:01:39 CET | Press release
Kioxia Installs Solar Power Generation Systems at Kitakami and Yokkaichi Plants in Japan in Major New Sustainability Initiative
ALIPAY+1.2.2023 03:28:40 CET | Press release
Alipay+ extends foodpanda partnership to Malaysia where customers can enjoy more convenient food and grocery deliveries by paying through the Touch ’n Go eWallet
JEOL1.2.2023 02:01:45 CET | Press release
JEOL: Launch of the FIB-SEM System “JIB-PS500i” with High Precision and High Resolution
NY-PHILIP-MORRIS-INTL31.1.2023 22:01:41 CET | Press release
PMI Recognized in 2023 Bloomberg Gender-Equality Index for Third Consecutive Year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom